(firstQuint)Study to Assess Safety and Quality of Life of Patients Using Biojector Versus Needles for Fuzeon Administration.

 This study is a "N of one" trial where the patient is their own control.

 We will provide the quality of life questionnaire, the MOS-HIV questionnaire; ISR questionnaire and a satisfaction questionnaire to patients that have used a standard need to inject enfuvirtide for at least one month.

 As well, demographics and laboratory data will be collected.

 The same procedures will be given 1 month after the use of Biojector in a follow-up visit.

.

 Study to Assess Safety and Quality of Life of Patients Using Biojector Versus Needles for Fuzeon Administration@highlight

Hypothesis: Patients using enfuvirtide with the Biojector have an improved quality of life, greater satisfaction, and fewer adverse events compared with using the standard needle.

